Word: genericizing
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...South African government has forced international pharmaceutical companies to back down from attempts to stop the country importing cheaper generic versions of patented AIDS treatment drugs. But even at the discount prices offered by manufacturers in India, the government of the cash-strapped African nation remains reluctant to invest the billions of dollars required to keep a burgeoning AIDS population alive. By inspiring them with his life and struggle to survive, Nkosi Johnson's dying has served as an indictment, not only of the South African authorities but of all the governments and corporations with the means to make...
...PERSONAL TIME: YOUR HEALTH, May 7] said that when children in the study were offered behavioral therapy alone, only five children showed improvement, while, when given Luvox, 76% showed swift improvement. Neither cognitive nor behavioral therapy was a component of this study. Dickinson mistakenly used "behavioral therapy" as a generic term referring to the "supportive therapy" offered to the children...
...patent expires in October. But if the drug's maker, British firm AstraZeneca, behaves like many of its counterparts in the industry, it won't easily relinquish its monopoly. Indeed, sources confirmed to TIME that the Federal Trade Commission has quietly launched an investigation into whether AstraZeneca illegally blocked generic competition to protect its Prilosec franchise. A company spokesperson said the firm would cooperate with the probe...
...drive by Washington to restrain the relentless rise of prescription prices, which remain the fastest-growing component of America's $1.3 trillion health-care bill. The action is on two fronts. The FTC, for its part, is going after brand-name drug companies that seek to block cheaper, copycat generic drugs from the marketplace. At the same time, a bipartisan duo of congressional lawmakers is pushing legislation designed to restrict those anticompetitive tactics and speed up government approval of generic medicines...
...Generic copies of the anti-retroviral "cocktail" therapies essential to staying the onset of full-blown AIDS can be acquired on the world market for as little as $250 a year per patient, as compared with a patent-protected price tag in the U.S. of $10,000 a year. But in a country with 4.7 million mostly deeply impoverished HIV patients, even the discounted drugs would require the government to lay out $1.2 billion a year - and to put in place the infrastructure to ensure the proper diagnosis and usage and create a healthy environment to protect those patients from...